The influence of heart failure co-morbidity on high-sensitivity troponin T levels in COPD exacerbation in a prospective cohort study: data from the Akershus cardiac examination (ACE) 2 study

References

• Abroug F, Ouanes-Besbes L, Nciri N, et al. (2006). Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174:990–6
   PubMed Web of Science ®Google Scholar
• Brekke PH, Omland T, Holmedal SH, et al. (2008a). Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 31:563–70
   PubMed Web of Science ®Google Scholar
• Brekke PH, Omland T, Smith P, Soyseth V. (2008b). Underdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 102:1243–7
   PubMed Web of Science ®Google Scholar
• Brekke PH, Omland T, Holmedal SH, et al. (2009). Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study. BMC Pulm Med 9:35
   PubMedGoogle Scholar
• Campo G, Pavasini R, Malagu M, et al. (2015). Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD. COPD 12:560–7
   PubMedGoogle Scholar
• Chang CL, Robinson SC, Mills GD, et al. (2011). Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 66:764–8
   PubMed Web of Science ®Google Scholar
• Chin CW, Shah AS, Mcallister DA, et al. (2014). High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J 35:2312–21
   Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. (2010). Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. Jama 304:2503–12
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, et al. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–442
   PubMed Web of Science ®Google Scholar
• Gold. (2015). From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org [last accessed 18 Dec 2015]
   Google Scholar
• Group NW, Wu AH, Jaffe AS, et al. (2007). National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 53:2086–96
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Petrie MC, Jhund PS, et al. (2009). Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–9
   PubMed Web of Science ®Google Scholar
• Hoiseth AD, Neukamm A, Karlsson BD, et al. (2011). Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 66:775–81
   PubMed Web of Science ®Google Scholar
• Hoiseth AD, Omland T, Hagve TA, et al. (2012). Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. BMC Pulm Med 12:22
   PubMed Web of Science ®Google Scholar
• Januzzi JLJR, Camargo CA, Anwaruddin S, et al. (2005). The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95:948–54
   PubMed Web of Science ®Google Scholar
• Jensen HH, Godtfredsen NS, Lange P, Vestbo J. (2006). Potential misclassification of causes of death from COPD. Eur Respir J 28:781–5
   PubMed Web of Science ®Google Scholar
• Knoll R, Iaccarino G, Tarone G, et al. (2011). Towards a re-definition of ‘cardiac hypertrophy’ through a rational characterization of left ventricular phenotypes: a position paper of the Working Group ’Myocardial Function’ of the ESC. Eur J Heart Fail 13:811–19
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, et al. (1999). Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1856–61
   PubMed Web of Science ®Google Scholar
• Mascarenhas J, Azevedo A, Bettencourt P. (2010). Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality. Curr Opin Pulm Med 16:106–11
   PubMed Web of Science ®Google Scholar
• McCullough PA, Nowak RM, Mccord J, et al. (2002). B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106:416–22
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–847
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Drazner MH, Berry JD, et al. (2013). Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol 61:187–95
   PubMed Web of Science ®Google Scholar
• Neukamm AM, Hoiseth AD, Hagve TA, et al. (2013). High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart 99:382–7
   PubMed Web of Science ®Google Scholar
• Omland T, de Lemos JA, Sabatine MS, et al. (2009). A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361:2538–47
   PubMed Web of Science ®Google Scholar
• Omland T, Pfeffer MA, Solomon SD, et al. (2013). Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 61:1240–9
   PubMed Web of Science ®Google Scholar
• Pavasini R, D’Ascenzo F, Campo G, et al. (2015). Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol 191:187–93
   PubMed Web of Science ®Google Scholar
• Rosjo H, Andreassen J, Edvardsen T, Omland T. (2011a). Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol 108:88–91
   PubMed Web of Science ®Google Scholar
• Rosjo H, Andreassen J, Edvardsen T, Omland T. (2011b). Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol 108:88–91
   PubMed Web of Science ®Google Scholar
• Rosjo H, Kravdal G, Hoiseth AD, et al. (2012). Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. Clin Chem 58:1565–73
   PubMed Web of Science ®Google Scholar
• Sidney S, Sorel M, Quesenberry CP, JR., et al. (2005). COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128:2068–75
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. (2005). Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2:8–11
   PubMedGoogle Scholar
• Soyseth V, Bhatnagar R, Holmedahl NH, et al. (2013). Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart 99:122–6
   PubMed Web of Science ®Google Scholar
• Stone IS, Petersen SE, Barnes NC. (2013). Raised troponin in COPD: clinical implications and possible mechanisms. Heart 99:71–2
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Giannitsis E, et al. Study group on biomarkers in cardiology of, E. S. C. W. G. O. A. C. C. (2012). How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 33:2252–7
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Almdal T, et al. (2006). Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173:79–83
   PubMed Web of Science ®Google Scholar
• White JM, Stewart RA. (2012). Troponin elevation during exacerbations of chronic obstructive airways disease due to stress cardiomyopathy. Int J Cardiol 160:206–7
   PubMed Web of Science ®Google Scholar